Masafumi Iguchi
Overview
Explore the profile of Masafumi Iguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suzuki K, Fumino S, Iguchi M, Takayama S, Kim K, Hirano S, et al.
Pediatr Surg Int
. 2024 Dec;
41(1):35.
PMID: 39699633
Purpose: The study reviewed a multidisciplinary approach to treating cervicofacial lymphatic malformations (CFLMs) in children. Methods: Between 2007 and 2023, 53 children with CFLMs were treated with the median on-set...
2.
Mimura K, Fumino S, Yamashi K, Iguchi M, Inoue M, Takayama S, et al.
Pediatr Surg Int
. 2024 Jul;
40(1):195.
PMID: 39017743
Background: We previously showed that total tumor resection enhances metastatic growth in a syngeneic metastatic mouse model of neuroblastoma. In this study, we further investigated which surgical factors contributed most...
3.
Takimoto A, Fumino S, Iguchi M, Takayama S, Kim K, Aoi S, et al.
Pediatr Surg Int
. 2024 Apr;
40(1):111.
PMID: 38641738
Background: Long-term urinary outcomes after anorectal malformation (ARM) repair are affected by surgical approach and sacral anomalies. This study aimed to compare laparoscopic-assisted anorectoplasty (LAARP) and posterior sagittal anorectoplasty (PSARP)...
4.
Nagayabu K, Fumino S, Shimamura A, Sengoku Y, Higashi M, Iguchi M, et al.
Front Pediatr
. 2024 Feb;
12:1338131.
PMID: 38318455
Introduction: Biliary atresia (BA) is a cholestatic hepatopathy caused by fibrosing destruction of intrahepatic and extrahepatic bile ducts, and its etiology has not been clearly revealed. In BA, liver fibrosis...
5.
Iguchi M, Yagyu S, Kambe K, Higashi M, Fumino S, Kishida T, et al.
Anticancer Res
. 2023 May;
43(6):2417-2424.
PMID: 37247922
Background/aim: Using the tyrosine hydroxylase (TH)-MYCN mouse neuroblastoma (NB) model, we have previously reported the accumulation of mouse mesenchymal stem cells (mMSCs) on tumors in vivo and the antitumor effect...
6.
Kambe K, Iguchi M, Higashi M, Yagyu S, Fumino S, Kishida T, et al.
Pediatr Surg Int
. 2022 Dec;
39(1):43.
PMID: 36484857
Purpose: Mouse IgG anti-disialoganglioside GD2 antibody-secreting mouse mesenchymal stem cells (anti-GD2-MSCs) were developed, and their anti-tumor effects were validated in an in vivo neuroblastoma mouse model. Methods: Anti-GD2 antibody constructs...
7.
Takimoto A, Fumino S, Iguchi M, Takemoto M, Takayama S, Kim K, et al.
BMC Pediatr
. 2022 Dec;
22(1):695.
PMID: 36463156
Background: Intrahepatic bile duct (IHBD) stones are one of the most common late complications of Roux-en-Y hepaticojejunostomy for congenital biliary dilatation (CBD). We report the current treatment strategies for IHBD...
8.
Ishimaru T, Kawashima H, Hattori K, Oiki H, Miyake K, Yanagida Y, et al.
J Laparoendosc Adv Surg Tech A
. 2022 Nov;
32(12):1234-1236.
PMID: 36350681
To evaluate the impact of previous infection on perioperative outcomes in patients undergoing thoracoscopic lobectomy for congenital lung anomalies. This was a single-institution retrospective observational study for which patients who...
9.
Kambe K, Nagata T, Kamiya H, Iguchi M, Kamada Y, Fukuda K, et al.
Gan To Kagaku Ryoho
. 2019 Jan;
45(13):2467-2469.
PMID: 30692500
In colorectal cancer perforation, selecting the appropriate surgical operation while considering the patient's life and radical treatment is important. We divided 15 patients who underwent surgical intervention at our department...
10.
Kamada Y, Kamiya H, Kambe K, Iguchi M, Nagata T, Fukuda K, et al.
Gan To Kagaku Ryoho
. 2019 Jan;
45(13):1958-1960.
PMID: 30692410
A 30-year-old woman was diagnosed with advanced gastric cancer(MUL, Circ, Type 4, por1+2, T4a, N3a, M1[LYM, P1, CY1, H0], Stage Ⅳ)on delivery. Because of unresectable, she underwent chemotherapy(first-line: S-1 plus...